This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1990 Jan 6;300(6716):22-3.

doi: 10.1136/bmj.300.6716.22.

Stimulating reporting of adverse drug reactions by using a fee

J Feely¹, S Moriarty, P O'Connor

Affiliations

PMID: 2105117
PMCID: PMC1661889
DOI: 10.1136/bmj.300.6716.22

Stimulating reporting of adverse drug reactions by using a fee

J Feely et al. BMJ. 1990.

. 1990 Jan 6;300(6716):22-3.

doi: 10.1136/bmj.300.6716.22.

Authors

J Feely¹, S Moriarty, P O'Connor

Affiliation

¹ Department of Pharmacology and Therapeutics, Trinity College Medical School, St James's Hospital, Dublin, Ireland.

PMID: 2105117
PMCID: PMC1661889
DOI: 10.1136/bmj.300.6716.22

No abstract available

PubMed Disclaimer

Similar articles

FDA proposes higher fees for drug approvals to cover postmarketing surveillance.
Tanne JH. Tanne JH. BMJ. 2007 Jan 27;334(7586):177. doi: 10.1136/bmj.39104.352616.DB. BMJ. 2007. PMID: 17255596 Free PMC article. No abstract available.
PDUFA reauthorization--drug safety's golden moment of opportunity?
Hennessy S, Strom BL. Hennessy S, et al. N Engl J Med. 2007 Apr 26;356(17):1703-4. doi: 10.1056/NEJMp078048. Epub 2007 Apr 13. N Engl J Med. 2007. PMID: 17435082 No abstract available.
The FDA Safety and Innovation Act.
Steinbrook R, Sharfstein JM. Steinbrook R, et al. JAMA. 2012 Oct 10;308(14):1437-8. doi: 10.1001/jama.2012.12829. JAMA. 2012. PMID: 23047356 No abstract available.
[Safety of medicinal products and reporting of adverse drug reactions].
Skibicka I, Maciejczyk A. Skibicka I, et al. Neurol Neurochir Pol. 2004 Nov-Dec;38(6):503-10. Neurol Neurochir Pol. 2004. PMID: 15654675 Review. Polish.
Post-marketing surveillance and adverse drug reactions.
Shani S. Shani S. Isr Med Assoc J. 1999 Oct;1(2):117-9. Isr Med Assoc J. 1999. PMID: 10731310 Review. No abstract available.

See all similar articles

Cited by

An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.
Pedrós C, Vallano A, Cereza G, Mendoza-Aran G, Agustí A, Aguilera C, Danés I, Vidal X, Arnau JM. Pedrós C, et al. Drug Saf. 2009;32(1):77-83. doi: 10.2165/00002018-200932010-00007. Drug Saf. 2009. PMID: 19132807
The spontaneous reporting of adverse drug reactions by nurses.
Hall M, McCormack P, Arthurs N, Feely J. Hall M, et al. Br J Clin Pharmacol. 1995 Aug;40(2):173-5. doi: 10.1111/j.1365-2125.1995.tb05774.x. Br J Clin Pharmacol. 1995. PMID: 8562303 Free PMC article.
Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
Abdel-Latif MM, Abdel-Wahab BA. Abdel-Latif MM, et al. Saudi Pharm J. 2015 Apr;23(2):154-61. doi: 10.1016/j.jsps.2014.07.005. Epub 2014 Jul 9. Saudi Pharm J. 2015. PMID: 25972735 Free PMC article.
A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme.
Bracchi RC, Houghton J, Woods FJ, Thomas S, Smail SA, Routledge PA. Bracchi RC, et al. Br J Clin Pharmacol. 2005 Aug;60(2):221-3. doi: 10.1111/j.1365-2125.2005.02419.x. Br J Clin Pharmacol. 2005. PMID: 16042677 Free PMC article.
UK veterinary professionals' perceptions and experiences of adverse drug reaction reporting.
Davies H, Pinchbeck G, Noble PM, Diesel G, Pirmohamed M, Anderson N, Killick DR. Davies H, et al. Vet Rec. 2022 Sep;191(6):e1796. doi: 10.1002/vetr.1796. Epub 2022 Jun 3. Vet Rec. 2022. PMID: 35665513 Free PMC article.

See all "Cited by" articles

References

1. Br Med J (Clin Res Ed). 1988 May 7;296(6632):1319 - PubMed
1. Br J Clin Pharmacol. 1988 Jul;26(1):1-5 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Medical
- MedlinePlus Health Information